The role of advanced lipid testing in the prediction of cardiovascular disease

Alvin Chandra, Anand Rohatgi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Advanced lipid testing has been suggested by some experts to identify patientswith substantial residual risk for more aggressive targeting of lifestyle and pharmacologic therapies. It measures the subpopulation of lipoproteins and apolipoproteins, which include lipoprotein (a), apolipoprotein A-I, and apolipoprotein B, and measures of lipoprotein particle composition such as LDL particle (LPL-P) and HDL particle (HDL-P) number and size. Obesity is associated with smaller LDL-P and HDL-P sizes. Moderate weight loss via fasting/calorie restriction is associated with LDL-P size increase, whereas moderate weight loss via endurance exercise is associated with HDL-P size increase. Diets high in carbohydrates are associated with a more atherogenic advanced lipoprotein profile characterized by smaller LDL-P and HDL-P sizes. In summary, lifestyle changes such as weight loss, exercise, and dietary modification correlate with improvement in the profile of advanced lipoproteins. Regrettably, therapies targeting HDL and HDL composition have been disappointing to date.

Original languageEnglish (US)
JournalCurrent Atherosclerosis Reports
Volume16
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Particle Size
Lipoproteins
Cardiovascular Diseases
Lipids
Weight Loss
Life Style
Diet Therapy
Lipoprotein(a)
Apolipoproteins
Apolipoprotein A-I
Apolipoproteins B
Fasting
Obesity
Carbohydrates
Diet
oxidized low density lipoprotein
Therapeutics

Keywords

  • Diet
  • Exercise
  • Lipoprotein
  • Particles

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The role of advanced lipid testing in the prediction of cardiovascular disease. / Chandra, Alvin; Rohatgi, Anand.

In: Current Atherosclerosis Reports, Vol. 16, No. 3, 03.2014.

Research output: Contribution to journalArticle

@article{60ce2e6dae3449b8a82ad9ffe92dbdc3,
title = "The role of advanced lipid testing in the prediction of cardiovascular disease",
abstract = "Advanced lipid testing has been suggested by some experts to identify patientswith substantial residual risk for more aggressive targeting of lifestyle and pharmacologic therapies. It measures the subpopulation of lipoproteins and apolipoproteins, which include lipoprotein (a), apolipoprotein A-I, and apolipoprotein B, and measures of lipoprotein particle composition such as LDL particle (LPL-P) and HDL particle (HDL-P) number and size. Obesity is associated with smaller LDL-P and HDL-P sizes. Moderate weight loss via fasting/calorie restriction is associated with LDL-P size increase, whereas moderate weight loss via endurance exercise is associated with HDL-P size increase. Diets high in carbohydrates are associated with a more atherogenic advanced lipoprotein profile characterized by smaller LDL-P and HDL-P sizes. In summary, lifestyle changes such as weight loss, exercise, and dietary modification correlate with improvement in the profile of advanced lipoproteins. Regrettably, therapies targeting HDL and HDL composition have been disappointing to date.",
keywords = "Diet, Exercise, Lipoprotein, Particles",
author = "Alvin Chandra and Anand Rohatgi",
year = "2014",
month = "3",
doi = "10.1007/s11883-013-0394-9",
language = "English (US)",
volume = "16",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - The role of advanced lipid testing in the prediction of cardiovascular disease

AU - Chandra, Alvin

AU - Rohatgi, Anand

PY - 2014/3

Y1 - 2014/3

N2 - Advanced lipid testing has been suggested by some experts to identify patientswith substantial residual risk for more aggressive targeting of lifestyle and pharmacologic therapies. It measures the subpopulation of lipoproteins and apolipoproteins, which include lipoprotein (a), apolipoprotein A-I, and apolipoprotein B, and measures of lipoprotein particle composition such as LDL particle (LPL-P) and HDL particle (HDL-P) number and size. Obesity is associated with smaller LDL-P and HDL-P sizes. Moderate weight loss via fasting/calorie restriction is associated with LDL-P size increase, whereas moderate weight loss via endurance exercise is associated with HDL-P size increase. Diets high in carbohydrates are associated with a more atherogenic advanced lipoprotein profile characterized by smaller LDL-P and HDL-P sizes. In summary, lifestyle changes such as weight loss, exercise, and dietary modification correlate with improvement in the profile of advanced lipoproteins. Regrettably, therapies targeting HDL and HDL composition have been disappointing to date.

AB - Advanced lipid testing has been suggested by some experts to identify patientswith substantial residual risk for more aggressive targeting of lifestyle and pharmacologic therapies. It measures the subpopulation of lipoproteins and apolipoproteins, which include lipoprotein (a), apolipoprotein A-I, and apolipoprotein B, and measures of lipoprotein particle composition such as LDL particle (LPL-P) and HDL particle (HDL-P) number and size. Obesity is associated with smaller LDL-P and HDL-P sizes. Moderate weight loss via fasting/calorie restriction is associated with LDL-P size increase, whereas moderate weight loss via endurance exercise is associated with HDL-P size increase. Diets high in carbohydrates are associated with a more atherogenic advanced lipoprotein profile characterized by smaller LDL-P and HDL-P sizes. In summary, lifestyle changes such as weight loss, exercise, and dietary modification correlate with improvement in the profile of advanced lipoproteins. Regrettably, therapies targeting HDL and HDL composition have been disappointing to date.

KW - Diet

KW - Exercise

KW - Lipoprotein

KW - Particles

UR - http://www.scopus.com/inward/record.url?scp=84892451535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892451535&partnerID=8YFLogxK

U2 - 10.1007/s11883-013-0394-9

DO - 10.1007/s11883-013-0394-9

M3 - Article

C2 - 24445969

AN - SCOPUS:84892451535

VL - 16

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 3

ER -